These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 33303253)
1. Leveraging digital tools to support recovery from substance use disorder during the COVID-19 pandemic response. McDonnell A; MacNeill C; Chapman B; Gilbertson N; Reinhardt M; Carreiro S J Subst Abuse Treat; 2021 May; 124():108226. PubMed ID: 33303253 [TBL] [Abstract][Full Text] [Related]
2. Online digital recovery support services: An overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond. Bergman BG; Kelly JF J Subst Abuse Treat; 2021 Jan; 120():108152. PubMed ID: 33129636 [TBL] [Abstract][Full Text] [Related]
3. Practical Technology for Expanding and Improving Substance Use Disorder Treatment: Telehealth, Remote Monitoring, and Digital Health Interventions. Sweeney MM; Holtyn AF; Stitzer ML; Gastfriend DR Psychiatr Clin North Am; 2022 Sep; 45(3):515-528. PubMed ID: 36055736 [TBL] [Abstract][Full Text] [Related]
4. Policies to Improve Substance Use Disorder Treatment With Telehealth During the COVID-19 Pandemic and Beyond. Drake C; Yu J; Lurie N; Kraemer K; Polsky D; Chaiyachati KH J Addict Med; 2020; 14(5):e139-e141. PubMed ID: 32826619 [TBL] [Abstract][Full Text] [Related]
5. Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States. Lin C; Pham H; Zhu Y; Clingan SE; Lin LA; Murphy SM; Campbell CI; Sorrell TR; Liu Y; Mooney LJ; Hser YI Drug Alcohol Depend; 2023 Jan; 242():109711. PubMed ID: 36462230 [TBL] [Abstract][Full Text] [Related]
6. Digital health technology for remote care in response to the COVID-19 pandemic: a scoping review. Choukou MA; Taha A; Qadeer A; Monnin C Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3386-3394. PubMed ID: 33928627 [TBL] [Abstract][Full Text] [Related]
7. Digital Clinical Trials for Substance Use Disorders in the Age of Covid-19. Brezing CA; Luo SX; Mariani JJ; Levin FR J Addict Med; 2020 Dec; 14(6):e297-e302. PubMed ID: 32956164 [TBL] [Abstract][Full Text] [Related]
8. [Telemedicine in rheumatology]. Krusche M; Mühlensiepen F; Aries P; Welcker M; Knitza J Z Rheumatol; 2020 Nov; 79(9):883-892. PubMed ID: 33057786 [TBL] [Abstract][Full Text] [Related]
9. The role of digital health technologies in COVID-19 surveillance and recovery: a specific case of long haulers. Southwick L; Guntuku SC; Klinger EV; Pelullo A; McCalpin H; Merchant RM Int Rev Psychiatry; 2021 Jun; 33(4):412-423. PubMed ID: 33860736 [TBL] [Abstract][Full Text] [Related]
10. Caring for women with substance use disorders through pregnancy and postpartum during the COVID-19 pandemic: Lessons learned from psychology trainees in an integrated OBGYN/substance use disorder outpatient treatment program. Sadicario JS; Parlier-Ahmad AB; Brechbiel JK; Islam LZ; Martin CE J Subst Abuse Treat; 2021 Mar; 122():108200. PubMed ID: 33250270 [TBL] [Abstract][Full Text] [Related]
11. Perceptions of Wearable Health Tools Post the COVID-19 Emergency in Low-Income Latin Communities: Qualitative Study. Cruz S; Lu C; Ulloa M; Redding A; Hester J; Jacobs M JMIR Mhealth Uhealth; 2024 May; 12():e50826. PubMed ID: 38717816 [TBL] [Abstract][Full Text] [Related]
12. Substance use treatment in Appalachian Tennessee amid COVID-19: Challenges and preparing for the future. Kedia SK; Schmidt M; Dillon PJ; Arshad H; Yu X J Subst Abuse Treat; 2021 May; 124():108270. PubMed ID: 33771275 [TBL] [Abstract][Full Text] [Related]
13. Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments. Melamed OC; deRuiter WK; Buckley L; Selby P Psychiatr Clin North Am; 2022 Mar; 45(1):95-107. PubMed ID: 35219445 [TBL] [Abstract][Full Text] [Related]
14. Digital health innovations in urology: telemedicine, wearables, and mobile applications - a systematic review of literature. Naik N; Talyshinskii A; Rassweiler J; Hameed BMZ; Somani BK Curr Opin Urol; 2024 Mar; 34(2):116-127. PubMed ID: 38038411 [TBL] [Abstract][Full Text] [Related]
15. Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook. Oesterle TS; Kolla B; Risma CJ; Breitinger SA; Rakocevic DB; Loukianova LL; Hall-Flavin DK; Gentry MT; Rummans TA; Chauhan M; Gold MS Mayo Clin Proc; 2020 Dec; 95(12):2709-2718. PubMed ID: 33276843 [TBL] [Abstract][Full Text] [Related]
16. Greenway of Digital Health Technology During COVID-19 Crisis: Bibliometric Analysis, Challenges, and Future Perspective. El-Sherif DM; Ahmed AA; Sharif AF; Elzarif MT; Abouzid M Adv Exp Med Biol; 2024; 1458():315-334. PubMed ID: 39102206 [TBL] [Abstract][Full Text] [Related]
17. Substance Use Disorder Treatment Through Telemedicine in the Age of CoVID-19. Onderdonk M; Goldstein N J Addict Nurs; 2023 Jan-Mar 01; 34(1):96-97. PubMed ID: 34678849 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a digital tool for detecting stress and craving in SUD recovery: An observational trial of accuracy and engagement. Carreiro S; Ramanand P; Taylor M; Leach R; Stapp J; Sherestha S; Smelson D; Indic P Drug Alcohol Depend; 2024 Aug; 261():111353. PubMed ID: 38917718 [TBL] [Abstract][Full Text] [Related]
20. Community Mental Health Care Delivery During the COVID-19 Pandemic: Practical Strategies for Improving Care for People with Serious Mental Illness. Kopelovich SL; Monroe-DeVita M; Buck BE; Brenner C; Moser L; Jarskog LF; Harker S; Chwastiak LA Community Ment Health J; 2021 Apr; 57(3):405-415. PubMed ID: 32562033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]